Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BY-NC-NDTranslational oncology

MSRB3 promotes gastric cancer progression and immunotherapy resistance by stabilizing GPX4 to inhibit ferroptosis

  • Jianqin Lai1
  • Taiwei Mo2
  • Jinxuan Su3
  • Zhijing Zhang4
  • Xiaofeng Zhou5
  • Chengxing Wang6
  • Qiuming Zou7
  • Sijia Li7
  • Xiaosong Zhuang7
  • Fangyuan Chen8
  • Qing Huang1
  • Jie Cao1
8 affiliations
  1. 1Department of General Surgery, School of Medicine, the Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital), Guangzhou, 510180, China
  2. 2Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510507, China
  3. 3Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China
  4. 4Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, 510632, China
  5. 5Department of Physiology, Zunyi Medical University, Zunyi, 563000, China
  6. 6Department of Gastrointestinal Surgery, Jiangmen Central Hospital, Jiangmen, 529000, China
  7. 7Department of Pharmacology, School of Medicine, Jinan University, Guangzhou, 510632, China
  8. 8Guangzhou Red Cross Hospital of Jinan University, Guangzhou, 510220, China
Read full textPDFCite

Related

  1. TPX2 promotes osteosarcoma progression by conferring ferroptosis resistance through the AURKA/NRF2 signaling axis
    Huashun Liu, Lan Tang, Biao Chen +1
    Journal of Bone OncologyPeer-reviewedCC BY-NC-ND 4.0Full textOncologyDOAJPMC
  2. The m6A reader IGF2BP2 promotes the progression of myelodysplastic syndromes by inhibiting ferroptosis through stabilizing GPX4 mRNA, which can be reversed by CWI1-2
    Wei Yujie, Li Mianyang
    陆军军医大学学报Peer-reviewedCC BYFull textGeneral medicineDOAJ
  3. CDCA5 promotes hepatocellular carcinoma progression by suppressing ferroptosis through PP2Ac/p53/STEAP3 signaling
    Di Wu, Haonan Zhou, Shiqi Liu +5
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  4. Sorting nexin 10 promotes triple-negative breast cancer progression through modulating cholesterol biosynthesis via stabilizing SREBP2.
    Yinping Guo, Jiahui Li, Wenjie Zhang +6
    Cancer biology & therapyPeer-reviewedCC BY-NCFull textOncologyEurope PMC
  5. ALDH2 Suppresses Ferroptosis and Promotes Bortezomib Resistance in Multiple Myeloma Through the KEAP1-NRF2 Feedback Loop.
    Ruonan Shao, Chengcheng Liu, Xinpei Deng +8
    Advanced science (Weinheim, Baden-Wurttemberg, Germany)Peer-reviewedCC BYFull textGeneral medicineEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{lai2026msrb3,
  title = {{MSRB3 promotes gastric cancer progression and immunotherapy resistance by stabilizing GPX4 to inhibit ferroptosis}},
  author = {Jianqin Lai and Taiwei Mo and Jinxuan Su and Zhijing Zhang and Xiaofeng Zhou and Chengxing Wang and Qiuming Zou and Sijia Li and Xiaosong Zhuang and Fangyuan Chen and Qing Huang and Jie Cao},
  journal = {Translational oncology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13691149},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - MSRB3 promotes gastric cancer progression and immunotherapy resistance by stabilizing GPX4 to inhibit ferroptosis
AU  - Jianqin Lai
AU  - Taiwei Mo
AU  - Jinxuan Su
AU  - Zhijing Zhang
AU  - Xiaofeng Zhou
AU  - Chengxing Wang
AU  - Qiuming Zou
AU  - Sijia Li
AU  - Xiaosong Zhuang
AU  - Fangyuan Chen
AU  - Qing Huang
AU  - Jie Cao
PY  - 2026
DA  - 2026/10/19
JO  - Translational oncology
UR  - https://europepmc.org/article/PMC/PMC13691149
SN  - 1936-5233
ER  -